Reneo Pharmaceuticals (RPHM) Investor Presentation

Focused on Improving the Lives of Patients with Rare Genetic Mitochondrial Diseases Nasdaq: RPHM September 2021 Forward-Looking Statements 2 This presentation may not be reproduced, retransmitted or further distributed to any other person or published, in whole or in part, for any other purpose. This presentation regarding Reneo Pharmaceuticals, Inc. (the "Company") is for you to familiarize yourself with the Company. This presentation is for information and education purposes only. No reliance may be place ...